anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Problem Agitate Solution

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 26,550
Current window 16,831-16,860
Pages 885
Rows per page 30
Arc: Problem Agitate Solutionclear collectionreset all
18 30 60

Arc

16,831-16,860 of 26,550

filter-aware
09
The slide uses a Q&A format to present anecdotal evidence from industry reps and a physician to challenge the market value of rapid diagnostic systems.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Problem (Identify pain)Loop · Zoom In1 hit
10
The slide uses a rhetorical question to challenge the value proposition of rapid diagnostics in the context of standard sepsis care protocols.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Agitate (Make it worse)1 hit
11
Image file not available at /tmp/legacy-images/dfcef8f28a20/slides/011.jpg; could not inspect.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Agitate (Make it worse)1 hit
12
The slide includes an embedded image of a conference presentation slide showing a diagnostic validity funnel.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Agitate (Make it worse)1 hit
13
The slide uses a screenshot of a company presentation to frame a contradiction, then provides a textual rebuttal based on study methodology.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Agitate (Make it worse)1 hit
14
The slide uses a timeline diagram to illustrate the reduction in time-to-result for blood culture testing.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Agitate (Make it worse)1 hit
15
The slide uses a timeline diagram and a comparison table to challenge AXDX's claimed 75% time advantage.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Agitate (Make it worse)1 hit
30
Includes a direct quote from Lawrence Mehren (CEO) to support the argument.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Solution (Provide relief)1 hit
31
The slide uses a skeptical tone to challenge management's guidance, citing specific quarterly placement figures (133, 75, 55) to highlight a downward trend.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
32
The text highlights a contradiction between management's narrative of 'better pricing' strategy and the observed low compliance in clinical studies.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
33
The slide contrasts positive clinical trial data (PHENOMENON study) with negative market sentiment from a sell-side analyst survey.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
34
The slide presents a bearish thesis on AXDX based on primary research (lab surveys) and reimbursement analysis.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
35
Includes a transcript excerpt from a Q2 2019 earnings call regarding NTAP program applications.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
36
The table compares T2 Biosystems (implied) vs Accelerate Diagnostics (AXDX).Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Solution (Provide relief)Loop · So What Cascade1 hit
37
The slide uses a narrative-driven argument to discredit the 'insider buying' signal often used by retail investors.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Solution (Provide relief)Loop · So What Cascade1 hit
38
The slide uses a table to list holdings and concludes with a negative recommendation based on historical performance.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Solution (Provide relief)Loop · So What Cascade1 hit
39
The slide uses a narrative of corporate governance and executive hierarchy to predict a 'reset' of market guidance.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Solution (Provide relief)Loop · So What Cascade1 hit
40
Research note by White Diamond Research, page 40.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Solution (Provide relief)Loop · So What Cascade1 hit
41
This is a short-seller research note.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Solution (Provide relief)1 hit
03
The slide uses a narrative structure to build a case for a short position, citing specific financial and regulatory risks.New Age Beverage Corp. (NBEV) · Grizzly Reports
Research note Short seller Beat · Problem1 hit
04
This is a research note page from Grizzly Reports detailing short-thesis arguments against NBEV.New Age Beverage Corp. (NBEV) · Grizzly Reports
Research note Short seller Beat · Problem1 hit
05
The slide uses a 'Grizzly Reports' branding, indicating a short-seller research note style.New Age Beverage Corp. (NBEV) · Grizzly Reports
Research note Short seller Beat · Problem1 hit
07
Grizzly Reports short-seller research note.New Age Beverage Corp. (NBEV) · Grizzly Reports
Research note Short seller Beat · Agitate1 hit
08
Image file not found at /tmp/legacy-images/9350276739a4/slides/008.jpg; cannot inspect.New Age Beverage Corp. (NBEV) · Grizzly Reports
Research note Short seller Beat · Agitate1 hit
09
Image file not found at /tmp/legacy-images/9350276739a4/slides/009.jpg; cannot inspect.New Age Beverage Corp. (NBEV) · Grizzly Reports
Research note Short seller Beat · Agitate1 hit
10
The slide contains photographic evidence of office premises, likely for a due diligence or investigative report.New Age Beverage Corp. (NBEV) · Grizzly Reports
Research note Short seller Beat · Agitate1 hit
11
The slide uses visual evidence to debunk a location claim.New Age Beverage Corp. (NBEV) · Grizzly Reports
Research note Short seller Beat · Agitate1 hit
12
The slide provides visual evidence of office locations for two specific branches, noting that their licenses are void.New Age Beverage Corp. (NBEV) · Grizzly Reports
Research note Short seller Beat · Agitate1 hit
13
Image file not found at /tmp/legacy-images/9350276739a4/slides/013.jpg; cannot inspect.New Age Beverage Corp. (NBEV) · Grizzly Reports
Research note Short seller Beat · Agitate1 hit
14
The slide uses a comparative case study approach to suggest that Morinda faces similar risks to NHTC, which previously suffered a stock price collapse following a CCTV exposé.New Age Beverage Corp. (NBEV) · Grizzly Reports
Research note Short seller Beat · Agitate1 hit